Laserfiche WebLink
STYRONTm 484 Natural Polystyrene <br />Safety Data Sheet <br />Ingestion <br />12.1. Toxicity <br />Data for Component: Styrene, 1,3 -butadiene copolymer (9003-55-8) <br />Not expected to be acutely toxic to aquatic organisms. Material is not classified as dangerous to aquatic <br />organisms (LC50/EC50/IC50/LL50/EL50 greater than 100 mg/L in most sensitive species). <br />Data for Component: White mineral oil (petroleum) (8042-47-5) <br />Material is practically non-toxic to aquatic organisms on an acute basis (LC50/EC50/EL50/LL50 >100 mg/L in the <br />most sensitive species tested). <br />Fish Acute & Prolonged Toxicity <br />LC50, Lepomis macrochirus (Bluegill sunfish), static test, 96 h, > 10,000 mg/I <br />LL50, Oncorhynchus mykiss (rainbow trout), static test, 96 h, > 100 mg/I <br />LL50, Leuciscus idus (Golden orfe), static test, 96 h, > 10,000 mg/I <br />Aquatic Invertebrate Acute Toxicity <br />LL50, Daphnia magna (Water flea), static test, , , > 100 mg/I <br />12.2. Persistence and Degradability <br />Data for Component: Styrene, 1,3 -butadiene copolymer(9003-55-8) <br />Based on information for a similar material: <br />Data for Component: White mineral oil (petroleum)(8042-47-5) <br />Based on stringent OECD test guidelines, this material cannot be considered as readily biodegradable however, <br />these results do not necessarily mean that the material is not biodegradable under environmental conditions. <br />OECD Biodearadation Tests: <br />Biodegradation Exposure Time Method 10 Day Window <br />0-24% 28 d OECD 301 B Test fail <br />Indirect Photode radation with OH Radicals: <br />Rate Constant Atmospheric Half-life Method <br />8.28E-12 cm3/s 1.291 d Estimated. <br />Theoretical Oxygen Demand: 3.50 mg/g <br />12.3. Bioaccumulative Potential <br />Data for Component: White mineral oil (petroleum)(8042-47-5) <br />Bioconcentration potential is high (BCF > 3000 or Log Pow between 5 and 7). <br />Bioconcentration Factor (BCF): 1,900; Fish; Estimated. <br />12.4. Mobility <br />No Additional Information. <br />12.5. Other Adverse Effects <br />No Additional Information. <br />05/08/2016 8/11 <br />